Fundraising Fox
/Companies
Sign in

Mcal Therapeutics

San Francisco, US · Founded 2020 · Delaware corporation · 1 known investors

Find your way into Mcal Therapeutics

Sign up to see every warm intro you have to Mcal Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Mcal Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Biotechnology company developing treatments for ophthalmic diseases, focusing on dry eye through a topical ophthalmology platform.

Biotech

Founders & leadership

Mcal Therapeutics was founded in 2020 by Tom Gadek.

TGTom Gadek
Tom GadekFounderTom Gadek founded MCAL Therapeutics and previously founded SARcode Biosciences, where he served as CEO until its acquisition by Shire in 2013; he earned a Ph.D. in synthetic organic chemistry from UC Berkeley and has over 70 patent inventions and peer-reviewed publications in pharmaceutical drug discovery and development.
CJ
Christopher J. MurphyNamed on SEC filing
CO
Charles O'NeillNamed on SEC filing
TS
Tanya ShnaydmanNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$6.3M disclosed across 2 rounds · 2020–2024

▶$5.9MraisedMar 2024 · 29 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Tom GadekExecutive Officer, Director
  • Charles O'NeillDirector
  • Chris J. MurphyDirector
  • Dan AlbertDirector
  • Tom MatherDirector
Offering amount
$5.9M
Amount sold
$5.9M
First sale
Mar 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$450KraisedJun 2020 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas GadekExecutive Officer, Director
  • Christopher J. MurphyDirector
  • Charles O'NeillExecutive Officer, Director
  • Tanya ShnaydmanExecutive Officer
Offering amount
$450K
Amount sold
$450K
First sale
May 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Mcal Therapeutics do?
Biotechnology company developing treatments for ophthalmic diseases, focusing on dry eye through a topical ophthalmology platform.
Who founded Mcal Therapeutics?
Mcal Therapeutics was founded by Tom Gadek in 2020.
Who are Mcal Therapeutics's investors?
Mcal Therapeutics's investors include OphthaFund.
How much funding has Mcal Therapeutics raised?
Mcal Therapeutics has disclosed $6.3M raised across 2 rounds.
Where is Mcal Therapeutics headquartered?
Mcal Therapeutics is headquartered in San Francisco, US.